Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection
Open Access
- 1 May 2001
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 19 (5) , 606-610
- https://doi.org/10.1016/s1010-7940(01)00662-5
Abstract
Objectives: To compare the medical treatment of chronic type B aortic dissection with β-blockers versus other antihypertensive treatments in terms ofKeywords
This publication has 16 references indexed in Scilit:
- Toward the Best Treatment for Uncomplicated Patients With Type B Acute Aortic Dissection : A Consideration for Sound Surgical IndicationCirculation, 1999
- MEDICAL TREATMENT OF THE AORTA ICardiology Clinics, 1999
- Phenotypic features and impact of Beta blocker or calcium antagonist therapy on Aortic lumen size in the Marfan syndromeThe American Journal of Cardiology, 1999
- Aortic dissection type A versus type B: a different post-surgical death hazard?European Journal of Cardio-Thoracic Surgery, 1997
- Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndromeThe American Journal of Cardiology, 1994
- Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's SyndromeNew England Journal of Medicine, 1994
- Arterial hemodynamic indexes in Marfan's syndrome.Circulation, 1989
- Effect of β-Adrenergic Blockade on the Growth Rate of Abdominal Aortic AneurysmsArchives of Surgery, 1988
- Influence of d-, l-, and dl-propranolol, and practolol on β-aminopropionitrile-induced aortic ruptures of turkeysToxicology and Applied Pharmacology, 1976
- Dissecting Aneurysm During Methonium TherapyBMJ, 1956